← Leaderboards
Mourad Tighiouart
Cedars-Sinai Medical Center
$4,304,711
Attributed
$5,138,040
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $809.6K · FY2009–24$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,138,040 · 6
By mechanism
R01$1,763,750 · 1
U01$1,666,658 · 1
P01$1,489,355 · 3
P30$218,277 · 1
Top collaborators
- Patricia A. Ganz3 shared
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Sarah-Jeanne Salvy$8,443,979
- Behzad Sharif$3,972,591
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelDesignSample SizeRandomizedProgramsResourcesMethodologyResearch MethodologyData Storage And RetrievalFoundationsComputing MethodologiesComputer SoftwareBaseResearch ProposalsEnsureResearch StudyComputersMathematical ModelManuscriptsCollaborationsDatabasesBiometryProceduresResearch Support
Grant awards (24)
Core C: Biostatistics Bioinformatics Core$109,589
P01 · FY2024 · CA · contact PI
Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials$350,000
U01 · FY2023 · CA · contact PI
Core C: Biostatistics Bioinformatics Core$139,578
P01 · FY2023 · CA · contact PI
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials$650,261
U01 · FY2022 · CA · contact PI
Core C: Biostatistics Bioinformatics Core$143,926
P01 · FY2022 · CA · contact PI
Advancing Analysis and Interpretation ofAdverse Events and PROs in Cancer Clinical Trials$666,397
U01 · FY2021 · CA · contact PI
Core C: Biostatistics Bioinformatics Core$143,205
P01 · FY2021 · CA · contact PI
Core C: Biostatistics Bioinformatics Core$136,921
P01 · FY2020 · CA · contact PI
Core A: Biostatistics and Bioinformatics Core$141,056
P01 · FY2019 · CA · contact PI
Core A: Biostatistics and Bioinformatics Core$95,440
P01 · FY2019 · CA · contact PI
Design of Cancer Phase I/II Clinical Trials Using Drug Combinations of Cytotoxic and Biologic Agents$352,750
R01 · FY2018 · CA · contact PI
Core A: Biostatistics and Bioinformatics Core$148,090
P01 · FY2018 · CA · contact PI
Core A: Biostatistics and Bioinformatics Core$2,669
P01 · FY2018 · CA · contact PI
Core A: Biostatistics and Bioinformatics Core$1,782
P01 · FY2018 · CA · contact PI
Design of Cancer Phase I/II Clinical Trials Using Drug Combinations of Cytotoxic and Biologic Agents$352,750
R01 · FY2017 · CA · contact PI
Core A: Biostatistics and Bioinformatics Core$121,627
P01 · FY2017 · CA · contact PI
Design of Cancer Phase I/II Clinical Trials Using Drug Combinations of Cytotoxic and Biologic Agents$352,750
R01 · FY2016 · CA · contact PI
Core A: Biostatistics and Bioinformatics Core$149,234
P01 · FY2016 · CA · contact PI
Design of Cancer Phase I/II Clinical Trials Using Drug Combinations of Cytotoxic and Biologic Agents$352,750
R01 · FY2015 · CA · contact PI
Core A: Biostatistics and Bioinformatics Core$156,238
P01 · FY2015 · CA · contact PI
Design of Cancer Phase I/II Clinical Trials Using Drug Combinations of Cytotoxic and Biologic Agents$352,750
R01 · FY2014 · CA · contact PI
BIOSTATISTICS CORE$68,349
P30 · FY2011 · CA · contact PI
BIOSTATISTICS CORE$78,226
P30 · FY2010 · CA · contact PI
BIOSTATISTICS CORE$71,702
P30 · FY2009 · CA · contact PI